Jürgen Drewe

Pharmacokinetics and Pharmacodynamic Effects of Oral GLP‐1 and PYY3‐36: A Proof‐of‐concept Study in Healthy Subjects

C. Beglinger, J. Drewe, I. Gómez-Orellana, 2008, Clinical pharmacology and therapeutics.

Enhancement of the oral absorption of cyclosporin in man.

T. Kissel, J. Drewe, K. Gyr, 1992, British journal of clinical pharmacology.

Interactions of HIV protease inhibitors with ATP-dependent drug export proteins.

J. Drewe, D. Miller, G. Fricker, 1999, Molecular pharmacology.

Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulation

J. Drewe, M. Keck, N. Mazer, 2004, European Journal of Clinical Pharmacology.

Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine.

W. Haefeli, H. Schächinger, C. Beglinger, 2000, British journal of clinical pharmacology.

Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation

C. Beglinger, J. Drewe, J. Huwyler, 1996, British journal of pharmacology.

Intranasal Midazolam: Pharmacokinetics and Pharmacodynamics Assessed by Quantitative EEG in Healthy Volunteers

P. Fuhr, S. Krähenbühl, R. Zimmermann, 2012, Clinical pharmacology and therapeutics.

Modulation of multidrug resistance protein expression in porcine brain capillary endothelial cells in vitro.

C. Beglinger, J. Drewe, J. Huwyler, 1999, Drug metabolism and disposition: the biological fate of chemicals.